These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23704574)

  • 1. Tetrahydrobiopterin biosynthesis as an off-target of sulfa drugs.
    Haruki H; Pedersen MG; Gorska KI; Pojer F; Johnsson K
    Science; 2013 May; 340(6135):987-91. PubMed ID: 23704574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfa drugs inhibit sepiapterin reduction and chemical redox cycling by sepiapterin reductase.
    Yang S; Jan YH; Mishin V; Richardson JR; Hossain MM; Heindel ND; Heck DE; Laskin DL; Laskin JD
    J Pharmacol Exp Ther; 2015 Mar; 352(3):529-40. PubMed ID: 25550200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfa hypersensitivity in patients with HIV infection: onset, treatment, critical review of the literature.
    Ryan C; Madalon M; Wortham DW; Graziano FM
    WMJ; 1998 May; 97(5):23-7. PubMed ID: 9617304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Side effects of trimethoprim-sulfamethoxazole in patients with AIDS].
    Weinke T; Sixt C; de Matos-Marques B; Ruf B; Pohle HD
    Dtsch Med Wochenschr; 1988 Jul; 113(28-29):1129-33. PubMed ID: 3260553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doses and side effects of co-trimoxazole in treatment of AIDS associated pneumocystis carinii pneumonia.
    Orlando G; Lazzarin A; Esposito R; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(4):332-3. PubMed ID: 3502075
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adverse effects of cotrimoxazole and Pneumocystis carinii pneumonia].
    Soler-Bel J; Tapiz A; Miralles R; Garcés JM
    Rev Clin Esp; 1989 Feb; 184(2):115-6. PubMed ID: 2787921
    [No Abstract]   [Full Text] [Related]  

  • 7. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
    White MV; Haddad ZH; Brunner E; Sainz C
    Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drugs for pneumocystosis].
    Furet Y; Duong TH; Perrotin D; Breteau M
    Therapie; 1988; 43(1):33-8. PubMed ID: 3128885
    [No Abstract]   [Full Text] [Related]  

  • 9. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L; Borio L; Masur H; Kovacs JA
    J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A possibility of therapeutic trial with tetrahydrobiopterin, which was suggested by the administration of sulfamethoxazole-trimethoprim].
    Sakai T
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1324-5. PubMed ID: 9128394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild rhabdomyolysis after high-dose trimethoprim-sulfamethoxazole in a patient with HIV infection.
    Anders HJ; Bogner JR; Goebel FD
    Eur J Med Res; 1997 May; 2(5):198-200. PubMed ID: 9153343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of Chlorobium tepidum sepiapterin reductase complex reveals the novel substrate binding mode for stereospecific production of L-threo-tetrahydrobiopterin.
    Supangat S; Seo KH; Choi YK; Park YS; Son D; Han CD; Lee KH
    J Biol Chem; 2006 Jan; 281(4):2249-56. PubMed ID: 16308317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
    Kazanjian P; Armstrong W; Hossler PA; Burman W; Richardson J; Lee CH; Crane L; Katz J; Meshnick SR
    J Infect Dis; 2000 Aug; 182(2):551-7. PubMed ID: 10915088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast.
    Patel O; Karnik K; Macreadie IG
    FEMS Microbiol Lett; 2004 Jul; 236(2):301-5. PubMed ID: 15251211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis choroiditis.
    Gupta A; Hustler A; Herieka E; Matthews BN
    Eye (Lond); 2010 Jan; 24(1):178. PubMed ID: 19325571
    [No Abstract]   [Full Text] [Related]  

  • 17. Cotrimoxazole induced toxic epidermal necrolysis in a suspected case of Pneumocystis carinii pneumonia with human immuno deficiency virus infection.
    Arora VK; Venubabu K
    Indian J Chest Dis Allied Sci; 1998; 40(2):125-9. PubMed ID: 9775570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6R-tetrahydrobiopterin biosynthesis: structures of rat and human sepiapterin reductase.
    Nagatsu T; Ichinose H; Katoh S; Fujita K; Titani K
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():510-3. PubMed ID: 1297798
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
    Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
    J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
    Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
    Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.